Abbott Laboratories (ABT)
113.11
+0.31
(+0.27%)
USD |
NYSE |
Dec 31, 16:00
113.13
+0.02
(+0.02%)
Pre-Market: 20:00
Abbott Laboratories Research and Development Expense (Annual): 2.741B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Boston Scientific Corp | 1.414B |
Haemonetics Corp | 54.44M |
ResMed Inc | 307.52M |
Globus Medical Inc | 124.01M |
Masimo Corp | 175.20M |